The epidemic of opioid use disorder has led to increased scrutiny of patients prescribed large amounts of controlled substances, such as opioids and benzodiazepines. States and payers, such as commercial insurers and Medicaid programs, are imposing stricter limits on prescribing opioids1 raising concerns that these policies may pressure physicians to discontinue opioid therapy.2,3 Because of the physical dependence inherent with long-term opioid or benzodiazepine use, individuals whose therapy is discontinued may resort to extreme measures to avoid withdrawal symptoms.4 The objective of this study was to examine the prescription patterns of family members of high-volume opioid or benzodiazepine users whose therapy is stopped. We hypothesized that when clinicians discontinue therapy for high-volume users, their family members may be more likely to obtain prescriptions for these medications to potentially divert those prescriptions to the high-volume user.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Barnett ML, Hicks TR, Jena AB. Prescription Patterns of Family Members After Discontinued Opioid or Benzodiazepine Therapy of Users. JAMA Intern Med. Published online July 01, 2019. doi:10.1001/jamainternmed.2019.1047
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: